Analysis of TCR/HLA/ peptide interaction and investigation of etiology of autoimmune diseases

TCR/HLA/肽相互作用分析及自身免疫性疾病病因学研究

基本信息

  • 批准号:
    11694294
  • 负责人:
  • 金额:
    $ 6.25万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

In the previous studies, we discovered assedations between specific HLA class II alleles and susceptibility to autoimmune diseases, and examined binding peptide motifs of disease-associated HLA class II molecules. In this study, to clarify the mechanisms of the disease-association of specific HLA alleles, we carried out the following researches. Identification of self peptides recognized by disease-related autoreactive T cell clones. We established many auto-antigen specific CD4^+ T cell clones from Asian type multiple sclerosis (MS) and anti-phosopholipid antibody syndrome (APS) patients. We identified many epitopes derived from self antigens and restricting HLA class II molecules, and examined the cytokines produced by the T cell clones. In addition, we searched for the target autoantigen of Vogt -Koyanagi-Harada disease (VKH), an autoimmune diseas e in which inflammatory disorders occur in multiple organs containing melanocytes. By SEREX method, we identified LEDGF (Lens Epithelial … More Cel l Derived Growth Factor) and UACA (Uveal Autoantigen with Coiled coil domains and Ankyrin repeats) as candidates for the target antigen. 2) Establishment of a method to identify cross-reactive epitopes recognized by disease-related autoreactive T cells.We established an expression cloning system to identify epitopes for CD4^+ T cell clones. Using this system, we examined the pattern of epitopes cross-recognized by two CD4^+ T cell clones established from Type I diabetes patients and specific to glutamate decarboxylase 65 (GAD65). Based on this information, we identified several mimicry epitopes of microbial antigen origin. 3) Analysis of T cell response induced by analogues of agonistic epilopes.We generated series of L cell transfectants expressing complexes of HLA-DR4 (DRB1^*0406) and agonist or partial agonist peptides in various densities. Using the transfectants, we discovered that a certain partial agonist peptide, when presented in a very high density, can induce T cell response in a similar magnitude as a full agonist peptide, andthat the T cell response is not accompanied by phosphorylation of ZAP-70 and LAT. We identified unique profiles of produced cytokines, down-modulation of TCR, and intracellular signaling events associated with this unique T cell response. Less
在之前的研究中,我们发现了特异性HLA II类等位基因与自身免疫性疾病易感性之间的关联,并检测了疾病相关HLA II类分子的结合肽基序。在本研究中,为了阐明特定HLA等位基因的疾病关联机制,我们进行了以下研究。疾病相关自身反应性T细胞克隆识别的自身肽的鉴定。我们从亚洲型多发性硬化症(MS)和抗磷脂抗体综合征(APS)患者中建立了许多自身抗原特异性CD4^+ T细胞克隆。我们从自身抗原和限制性HLA II类分子中鉴定了许多表位,并检测了T细胞克隆产生的细胞因子。此外,我们寻找Vogt -Koyanagi-Harada病(VKH)的靶自身抗原,VKH是一种自身免疫性疾病,炎症性疾病发生在含有黑素细胞的多个器官中。通过SEREX方法,我们鉴定出LEDGF(晶状体上皮细胞衍生生长因子)和UACA(具有卷曲线圈结构域和锚蛋白重复序列的葡萄膜自身抗原)作为候选靶抗原。2)建立疾病相关自身反应性T细胞识别的交叉反应性表位的鉴定方法。我们建立了一个表达克隆系统来鉴定CD4^+ T细胞克隆的表位。利用该系统,我们检测了来自1型糖尿病患者的两个CD4^+ T细胞克隆交叉识别的表位模式,这些克隆对谷氨酸脱羧酶65 (GAD65)具有特异性。基于这些信息,我们确定了几个微生物抗原来源的模仿表位。3)拮抗癫痫类似物诱导的T细胞应答分析。我们生成了一系列表达HLA-DR4 (DRB1^*0406)复合物和不同密度的激动剂或部分激动剂肽的L细胞转染物。使用这些转染物,我们发现,当以非常高的密度呈现时,某种部分激动剂肽可以诱导T细胞反应,其强度与完全激动剂肽相似,并且T细胞反应不伴随着ZAP-70和LAT的磷酸化。我们确定了产生的细胞因子的独特特征,TCR的下调,以及与这种独特的T细胞反应相关的细胞内信号事件。少

项目成果

期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shigematsu, H.: "Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis : implications for molecular mimicry and cross-recognition among mitochondrial autoantigens"Hepatology. 32.
Shigematsu, H.:“T 细胞对人 PDC-E2 163-176 肽(原发性胆汁性肝硬化中的免疫显性自身抗原)反应的精细特异性:对线粒体自身抗原之间的分子模拟和交叉识别的影响”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
西村泰治: "T細胞抗原受容体におけるリガンドと伝達シグナルの多様性:抗原の質的変化が応答に及ぼす影響"細胞工学. 19・2. 228-238 (2000)
Taiji Nishimura:“T细胞抗原受体中配体和转导信号的多样性:抗原的质变对反应的影响”《细胞工程》19・2(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Minohara, M.: "Differences between T cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls"Tissue Antigens. 57. 447-456 (2001)
Minohara, M.:“视脊髓和传统形式的多发性硬化症和健康对照中 T 细胞对主要髓磷脂蛋白衍生肽的反应性之间的差异”组织抗原。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
伊藤裕志: "HLAクラスII分子による抗原提示と疾患感受性"Molecular Medicine特集「ゲノム多様性と機能解析-MHC多型と疾患感受性」. 37・5. 558-570 (2000)
伊藤博:“HLA II 类分子的抗原呈递和疾病易感性”分子医学专题“基因组多样性和功能分析 - MHC 多态性和疾病易感性”37・5。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yun, C.: "Augmentation of immune response by altered peptide ligands of the antigenic peptide in a human CD4^+ T-cell clone reacting to TEL/AML1 fusion protein"Tissue Antigens. 54. 153-161 (1999)
Yun, C.:“在与 TEL/AML1 融合蛋白反应的人 CD4+ T 细胞克隆中,通过改变抗原肽的肽配体来增强免疫应答”组织抗原。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIMURA Yasuharu其他文献

NISHIMURA Yasuharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIMURA Yasuharu', 18)}}的其他基金

Development of new cancer immunotherapy aiming activation of both anti-tumor killer and helper T cells
开发新的癌症免疫疗法,旨在激活抗肿瘤杀伤细胞和辅助 T 细胞
  • 批准号:
    24300334
  • 财政年份:
    2012
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of cellular cancer immunotherapy by using humaniPS-cell-derived dendritic cells and ideal cancer-associated antigens
利用人PS细胞衍生的树突状细胞和理想的癌症相关抗原开发细胞癌症免疫疗法
  • 批准号:
    23650609
  • 财政年份:
    2011
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Investigation on the molecular mechanisms of antigen presentation and recognition.
抗原呈递和识别的分子机制研究。
  • 批准号:
    14370115
  • 财政年份:
    2002
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of tumor-specific antigens recognized by human T cells
人类 T 细胞识别的肿瘤特异性抗原的鉴定
  • 批准号:
    12213111
  • 财政年份:
    2000
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
THE DIVESITY IN ANTIGEN RECOGNITION AND RESPONSE OF ANTIGEN-SPECIFIC HUMAN CD4^+ T-CELL CLONES
抗原特异性人类 CD4^ T 细胞克隆的抗原识别和反应的多样性
  • 批准号:
    11557027
  • 财政年份:
    1999
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ANALYSIS OF AUTOANTIGENIC PEPTIDE-HLA CLASS II COMPLEXES ASSOCIATED WITH AUTOIMMUNE DISEASES
与自身免疫性疾病相关的自身抗原肽-HLA II 类复合物的分析
  • 批准号:
    09470097
  • 财政年份:
    1997
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
An approach to generate a library of CHO cells expressing diverse HLA class II plus peptide complexes for identification of TCR-ligands by using CLIP-substituted invariant chains
一种生成表达多种 HLA II 类加肽复合物的 CHO 细胞文库的方法,用于通过使用 CLIP 取代的不变链鉴定 TCR 配体
  • 批准号:
    08557027
  • 财政年份:
    1996
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
IDENTIFICATION AND PREDICTION OF T-CELL EPITOPES BY USING HLA CLASS II-BINDING PEPTIDE MOTIFS
使用 HLA II 类结合肽基序识别和预测 T 细胞表位
  • 批准号:
    06454222
  • 财政年份:
    1994
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effects of polymorphism of HLA on binding of antigenic peptides to HLA and recognition of peptides complexed with HLA by T cell receptor
HLA多态性对抗原肽与HLA结合及T细胞受体识别HLA复合肽的影响
  • 批准号:
    03452276
  • 财政年份:
    1991
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Production of monoclonal antibody specific to HLA by utilizing HLA transgenic mice.
利用 HLA 转基因小鼠生产 HLA 特异性单克隆抗体。
  • 批准号:
    01870026
  • 财政年份:
    1989
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research

相似海外基金

Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
  • 批准号:
    10568864
  • 财政年份:
    2023
  • 资助金额:
    $ 6.25万
  • 项目类别:
Elucidation of the novel mechanism of multiple sclerosis based on the molecular mimicry between gut microbial and myelin antigens
基于肠道微生物和髓磷脂抗原之间的分子模拟阐明多发性硬化症的新机制
  • 批准号:
    23K14765
  • 财政年份:
    2023
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
RAPID: Bioinformatic Search for Epitope-based Molecular Mimicry in the SARS-CoV-2 Virus using Chameleon
RAPID:使用 Chameleon 对 SARS-CoV-2 病毒中基于表位的分子拟态进行生物信息搜索
  • 批准号:
    2037374
  • 财政年份:
    2020
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Standard Grant
The diagnosis and strategy for prevention of Behcet's disease based on molecular mimicry.
基于分子拟态的白塞病诊断及预防策略。
  • 批准号:
    16K11839
  • 财政年份:
    2016
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Diagnosis and treatments of cardiovascular diseases associated with molecular mimicry between periodontopathic bacteria and ApoH
牙周病细菌与ApoH分子模拟相关的心血管疾病的诊断和治疗
  • 批准号:
    26463141
  • 财政年份:
    2014
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular Mimicry in Immune Mediated Neurologic Disease
免疫介导的神经系统疾病中的分子拟态
  • 批准号:
    8680007
  • 财政年份:
    2013
  • 资助金额:
    $ 6.25万
  • 项目类别:
Molecular Mimicry in Immune Mediated Neurologic Disease
免疫介导的神经系统疾病中的分子拟态
  • 批准号:
    8971987
  • 财政年份:
    2013
  • 资助金额:
    $ 6.25万
  • 项目类别:
Molecular Mimicry in Immune Mediated Neurologic Disease
免疫介导的神经系统疾病中的分子拟态
  • 批准号:
    8536552
  • 财政年份:
    2013
  • 资助金额:
    $ 6.25万
  • 项目类别:
Molecular Mimicry in Immune Mediated Neurologic Disease
免疫介导的神经系统疾病中的分子拟态
  • 批准号:
    8774197
  • 财政年份:
    2013
  • 资助金额:
    $ 6.25万
  • 项目类别:
Basic study to understand "molecular mimicry" of the host by parasitic wasp embryos
了解寄生黄蜂胚胎对宿主的“分子拟态”的基础研究
  • 批准号:
    22658015
  • 财政年份:
    2010
  • 资助金额:
    $ 6.25万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了